Companies / RAPT Therapeutics, Inc. / Activity
Activity — RAPT Therapeutics, Inc.
10 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q4 2023 as of | Barclays PLC 13F manager | Add | Common stock | $616.8K | +25K +46.27% | 78,473 0.28% of shares | low |
| Q1 2023 as of | Barclays PLC 13F manager | Trim | Common stock | $-543.5K | -30K -37.18% | 50,034 0.18% of shares | low |
| Q2 2023 as of | Barclays PLC 13F manager | Add | Common stock | $269.3K | +14K +28.78% | 64,436 0.23% of shares | low |
| Q2 2024 as of | Barclays PLC 13F manager | Trim | Common stock | $-250.4K | -82K -88.63% | 10,534 0.04% of shares | low |
| Q3 2023 as of | Barclays PLC 13F manager | Trim | Common stock | $-179.2K | -11K -16.74% | 53,651 0.19% of shares | low |
| Q1 2024 as of | Barclays PLC 13F manager | Add | Common stock | $127.0K | +14K +18.02% | 92,617 0.33% of shares | low |
| Q3 2024 as of | Barclays PLC 13F manager | Add | Common stock | $58.7K | +29K +277.15% | 39,729 0.14% of shares | low |
| Q2 2025 as of | Barclays PLC 13F manager | Exit | Common stock | $-42.7K | -35K -100.00% | 0 | low |
| Q1 2025 as of | Barclays PLC 13F manager | Trim | Common stock | $-12.5K | -10K -22.62% | 34,977 0.13% of shares | low |
| Q4 2024 as of | Barclays PLC 13F manager | Add | Common stock | $8.6K | +5K +13.78% | 45,203 0.16% of shares | low |